Retinoic acid receptor and retinoid X receptor alterations in lung cancer precursor lesions
Smoking prevention will decrease lung cancer incidence in time. However, early detection would improve lung cancer prognosis in subjects at risk provided that specific markers could be identified. We previously reported that retinoic acid receptor (RAR) and retinoid X receptor (RXR) expression was a...
Gespeichert in:
Veröffentlicht in: | Cancer research (Chicago, Ill.) Ill.), 2000-06, Vol.60 (11), p.2869-2875 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2875 |
---|---|
container_issue | 11 |
container_start_page | 2869 |
container_title | Cancer research (Chicago, Ill.) |
container_volume | 60 |
creator | MARTINET, N ALLA, F BORELLY, J VERMYLEN, P BAZARBACHI, T VIGNAUD, J.-M MARTINET, Y FARRE, G LABIB, T DROUOT, H VIDILI, R PICARD, E GAUBE, M.-P LE FAOU, D SIAT, J |
description | Smoking prevention will decrease lung cancer incidence in time. However, early detection would improve lung cancer prognosis in subjects at risk provided that specific markers could be identified. We previously reported that retinoic acid receptor (RAR) and retinoid X receptor (RXR) expression was altered in lung tumors. RAR-beta gene status could be derived from corresponding allelotyping and immunohistochemistry data. We now report the continued study on lung cancer precursor lesions. Fluorescence PCR-based assays were used for allelotyping at the RAR/RXR loci of: (a) 66 lung precursor lesions found at the free resection margins of 41 patients undergoing surgery for lung cancer (+ 31 paired tumors); and (b) bronchial cells also found at the free resection margins from 16 current and 8 never smokers operated on for noncancerous diseases. Three microsatellites located at 3p14-21 and 9p21 were also used for interwork comparison. Immunohistochemistry was additionally performed to evaluate P53 and RAR-beta expression in precursor lesions. Chi2 tests showed significant differences (P < 0.05) when comparing the results obtained from never smokers, smokers, squamous metaplasia, dysplasia + in situ carcinoma, and tumors. Microsatellite changes occurred frequently in all samples, but without specificity for any group (P < 0.08-0.52). They were globally correlated with tobacco exposure (P < 0.04), for which the RAR-gamma marker appeared as a preferential target (P < 0.004). Few reparation error phenotypes were observed, mostly at the RXR-alpha and RXR-gamma markers for which combined changes were also linearly increasing from never smokers to dysplasia + in situ carcinoma (P < 0.05 and P < 0.03). RAR-beta marker losses also increased from the first to the last group studied (P < 0.01), with a concomitant decrease in RAR-beta protein expression and correlated p53 increased immunoreactivity (P < 0.02). Losses at 3p14, 3p21, and P16 were frequent, but no significant differences between groups could be found. Unexpectedly, high constitutive homozygosity was observed near the RAR-alpha locus in squamous cell lung cancer cases. RARs/RXRs form homodimers or heterodimers involved in ligand binding. Their added alterations could result in a state of functional vitamin A deficiency in the affected bronchial cells. Further deletion events drawn from a limited repertoire of specific regions such as 3p14-21 and 9p21 could subsequently drive the deficient cells to invasive carci |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71179655</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71179655</sourcerecordid><originalsourceid>FETCH-LOGICAL-h270t-322a686e6634f0b8f783ad12ae380876a8c89dd8a00415b77d18c996b3aafac13</originalsourceid><addsrcrecordid>eNpN0E1LxDAQBuAgiruu_gXJQbwVkuazR1nUFRYEURA8lGmSaiRNa9Ie_Pd2dUVPwzvzMDBzgJZUMF0ozsUhWhJCdCG4KhfoJOf3OQpKxDFaUKIF4Yws0cuDG33svcFgvMXJGTeMfcIQd-F7ZPHzv34YXYLR9zFjH3GY4is2EI1LeJjRlPKMgss7cIqOWgjZne3rCj3dXD-uN8X2_vZufbUt3kpFxoKVJUgtnZSMt6TRrdIMLC3BMU20kqCNrqzVQAinolHKUm2qSjYMoAVD2Qpd_uwdUv8xuTzWnc_GhQDR9VOuFaWqkkLM8HwPp6Zzth6S7yB91r_vmMHFHkA2ENo0X-bzn-Mlr4RmX_YBaiY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71179655</pqid></control><display><type>article</type><title>Retinoic acid receptor and retinoid X receptor alterations in lung cancer precursor lesions</title><source>MEDLINE</source><source>American Association for Cancer Research</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>MARTINET, N ; ALLA, F ; BORELLY, J ; VERMYLEN, P ; BAZARBACHI, T ; VIGNAUD, J.-M ; MARTINET, Y ; FARRE, G ; LABIB, T ; DROUOT, H ; VIDILI, R ; PICARD, E ; GAUBE, M.-P ; LE FAOU, D ; SIAT, J</creator><creatorcontrib>MARTINET, N ; ALLA, F ; BORELLY, J ; VERMYLEN, P ; BAZARBACHI, T ; VIGNAUD, J.-M ; MARTINET, Y ; FARRE, G ; LABIB, T ; DROUOT, H ; VIDILI, R ; PICARD, E ; GAUBE, M.-P ; LE FAOU, D ; SIAT, J</creatorcontrib><description><![CDATA[Smoking prevention will decrease lung cancer incidence in time. However, early detection would improve lung cancer prognosis in subjects at risk provided that specific markers could be identified. We previously reported that retinoic acid receptor (RAR) and retinoid X receptor (RXR) expression was altered in lung tumors. RAR-beta gene status could be derived from corresponding allelotyping and immunohistochemistry data. We now report the continued study on lung cancer precursor lesions. Fluorescence PCR-based assays were used for allelotyping at the RAR/RXR loci of: (a) 66 lung precursor lesions found at the free resection margins of 41 patients undergoing surgery for lung cancer (+ 31 paired tumors); and (b) bronchial cells also found at the free resection margins from 16 current and 8 never smokers operated on for noncancerous diseases. Three microsatellites located at 3p14-21 and 9p21 were also used for interwork comparison. Immunohistochemistry was additionally performed to evaluate P53 and RAR-beta expression in precursor lesions. Chi2 tests showed significant differences (P < 0.05) when comparing the results obtained from never smokers, smokers, squamous metaplasia, dysplasia + in situ carcinoma, and tumors. Microsatellite changes occurred frequently in all samples, but without specificity for any group (P < 0.08-0.52). They were globally correlated with tobacco exposure (P < 0.04), for which the RAR-gamma marker appeared as a preferential target (P < 0.004). Few reparation error phenotypes were observed, mostly at the RXR-alpha and RXR-gamma markers for which combined changes were also linearly increasing from never smokers to dysplasia + in situ carcinoma (P < 0.05 and P < 0.03). RAR-beta marker losses also increased from the first to the last group studied (P < 0.01), with a concomitant decrease in RAR-beta protein expression and correlated p53 increased immunoreactivity (P < 0.02). Losses at 3p14, 3p21, and P16 were frequent, but no significant differences between groups could be found. Unexpectedly, high constitutive homozygosity was observed near the RAR-alpha locus in squamous cell lung cancer cases. RARs/RXRs form homodimers or heterodimers involved in ligand binding. Their added alterations could result in a state of functional vitamin A deficiency in the affected bronchial cells. Further deletion events drawn from a limited repertoire of specific regions such as 3p14-21 and 9p21 could subsequently drive the deficient cells to invasive carcinoma.]]></description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>PMID: 10850430</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Alleles ; Biological and medical sciences ; Bronchi - metabolism ; Carcinoma in Situ - metabolism ; Epithelium - metabolism ; Female ; Genotype ; Humans ; Immunohistochemistry ; Lung Neoplasms - diagnosis ; Lung Neoplasms - genetics ; Lung Neoplasms - metabolism ; Male ; Medical sciences ; Mesothelioma - genetics ; Mesothelioma - metabolism ; Microsatellite Repeats ; Pneumology ; Precancerous Conditions - diagnosis ; Precancerous Conditions - genetics ; Precancerous Conditions - metabolism ; Receptors, Retinoic Acid - biosynthesis ; Receptors, Retinoic Acid - genetics ; Retinoid X Receptors ; Smoking ; Transcription Factors - biosynthesis ; Transcription Factors - genetics ; Tumors of the respiratory system and mediastinum</subject><ispartof>Cancer research (Chicago, Ill.), 2000-06, Vol.60 (11), p.2869-2875</ispartof><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1424958$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10850430$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MARTINET, N</creatorcontrib><creatorcontrib>ALLA, F</creatorcontrib><creatorcontrib>BORELLY, J</creatorcontrib><creatorcontrib>VERMYLEN, P</creatorcontrib><creatorcontrib>BAZARBACHI, T</creatorcontrib><creatorcontrib>VIGNAUD, J.-M</creatorcontrib><creatorcontrib>MARTINET, Y</creatorcontrib><creatorcontrib>FARRE, G</creatorcontrib><creatorcontrib>LABIB, T</creatorcontrib><creatorcontrib>DROUOT, H</creatorcontrib><creatorcontrib>VIDILI, R</creatorcontrib><creatorcontrib>PICARD, E</creatorcontrib><creatorcontrib>GAUBE, M.-P</creatorcontrib><creatorcontrib>LE FAOU, D</creatorcontrib><creatorcontrib>SIAT, J</creatorcontrib><title>Retinoic acid receptor and retinoid X receptor alterations in lung cancer precursor lesions</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description><![CDATA[Smoking prevention will decrease lung cancer incidence in time. However, early detection would improve lung cancer prognosis in subjects at risk provided that specific markers could be identified. We previously reported that retinoic acid receptor (RAR) and retinoid X receptor (RXR) expression was altered in lung tumors. RAR-beta gene status could be derived from corresponding allelotyping and immunohistochemistry data. We now report the continued study on lung cancer precursor lesions. Fluorescence PCR-based assays were used for allelotyping at the RAR/RXR loci of: (a) 66 lung precursor lesions found at the free resection margins of 41 patients undergoing surgery for lung cancer (+ 31 paired tumors); and (b) bronchial cells also found at the free resection margins from 16 current and 8 never smokers operated on for noncancerous diseases. Three microsatellites located at 3p14-21 and 9p21 were also used for interwork comparison. Immunohistochemistry was additionally performed to evaluate P53 and RAR-beta expression in precursor lesions. Chi2 tests showed significant differences (P < 0.05) when comparing the results obtained from never smokers, smokers, squamous metaplasia, dysplasia + in situ carcinoma, and tumors. Microsatellite changes occurred frequently in all samples, but without specificity for any group (P < 0.08-0.52). They were globally correlated with tobacco exposure (P < 0.04), for which the RAR-gamma marker appeared as a preferential target (P < 0.004). Few reparation error phenotypes were observed, mostly at the RXR-alpha and RXR-gamma markers for which combined changes were also linearly increasing from never smokers to dysplasia + in situ carcinoma (P < 0.05 and P < 0.03). RAR-beta marker losses also increased from the first to the last group studied (P < 0.01), with a concomitant decrease in RAR-beta protein expression and correlated p53 increased immunoreactivity (P < 0.02). Losses at 3p14, 3p21, and P16 were frequent, but no significant differences between groups could be found. Unexpectedly, high constitutive homozygosity was observed near the RAR-alpha locus in squamous cell lung cancer cases. RARs/RXRs form homodimers or heterodimers involved in ligand binding. Their added alterations could result in a state of functional vitamin A deficiency in the affected bronchial cells. Further deletion events drawn from a limited repertoire of specific regions such as 3p14-21 and 9p21 could subsequently drive the deficient cells to invasive carcinoma.]]></description><subject>Alleles</subject><subject>Biological and medical sciences</subject><subject>Bronchi - metabolism</subject><subject>Carcinoma in Situ - metabolism</subject><subject>Epithelium - metabolism</subject><subject>Female</subject><subject>Genotype</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Lung Neoplasms - diagnosis</subject><subject>Lung Neoplasms - genetics</subject><subject>Lung Neoplasms - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mesothelioma - genetics</subject><subject>Mesothelioma - metabolism</subject><subject>Microsatellite Repeats</subject><subject>Pneumology</subject><subject>Precancerous Conditions - diagnosis</subject><subject>Precancerous Conditions - genetics</subject><subject>Precancerous Conditions - metabolism</subject><subject>Receptors, Retinoic Acid - biosynthesis</subject><subject>Receptors, Retinoic Acid - genetics</subject><subject>Retinoid X Receptors</subject><subject>Smoking</subject><subject>Transcription Factors - biosynthesis</subject><subject>Transcription Factors - genetics</subject><subject>Tumors of the respiratory system and mediastinum</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpN0E1LxDAQBuAgiruu_gXJQbwVkuazR1nUFRYEURA8lGmSaiRNa9Ie_Pd2dUVPwzvzMDBzgJZUMF0ozsUhWhJCdCG4KhfoJOf3OQpKxDFaUKIF4Yws0cuDG33svcFgvMXJGTeMfcIQd-F7ZPHzv34YXYLR9zFjH3GY4is2EI1LeJjRlPKMgss7cIqOWgjZne3rCj3dXD-uN8X2_vZufbUt3kpFxoKVJUgtnZSMt6TRrdIMLC3BMU20kqCNrqzVQAinolHKUm2qSjYMoAVD2Qpd_uwdUv8xuTzWnc_GhQDR9VOuFaWqkkLM8HwPp6Zzth6S7yB91r_vmMHFHkA2ENo0X-bzn-Mlr4RmX_YBaiY</recordid><startdate>20000601</startdate><enddate>20000601</enddate><creator>MARTINET, N</creator><creator>ALLA, F</creator><creator>BORELLY, J</creator><creator>VERMYLEN, P</creator><creator>BAZARBACHI, T</creator><creator>VIGNAUD, J.-M</creator><creator>MARTINET, Y</creator><creator>FARRE, G</creator><creator>LABIB, T</creator><creator>DROUOT, H</creator><creator>VIDILI, R</creator><creator>PICARD, E</creator><creator>GAUBE, M.-P</creator><creator>LE FAOU, D</creator><creator>SIAT, J</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20000601</creationdate><title>Retinoic acid receptor and retinoid X receptor alterations in lung cancer precursor lesions</title><author>MARTINET, N ; ALLA, F ; BORELLY, J ; VERMYLEN, P ; BAZARBACHI, T ; VIGNAUD, J.-M ; MARTINET, Y ; FARRE, G ; LABIB, T ; DROUOT, H ; VIDILI, R ; PICARD, E ; GAUBE, M.-P ; LE FAOU, D ; SIAT, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h270t-322a686e6634f0b8f783ad12ae380876a8c89dd8a00415b77d18c996b3aafac13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Alleles</topic><topic>Biological and medical sciences</topic><topic>Bronchi - metabolism</topic><topic>Carcinoma in Situ - metabolism</topic><topic>Epithelium - metabolism</topic><topic>Female</topic><topic>Genotype</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Lung Neoplasms - diagnosis</topic><topic>Lung Neoplasms - genetics</topic><topic>Lung Neoplasms - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mesothelioma - genetics</topic><topic>Mesothelioma - metabolism</topic><topic>Microsatellite Repeats</topic><topic>Pneumology</topic><topic>Precancerous Conditions - diagnosis</topic><topic>Precancerous Conditions - genetics</topic><topic>Precancerous Conditions - metabolism</topic><topic>Receptors, Retinoic Acid - biosynthesis</topic><topic>Receptors, Retinoic Acid - genetics</topic><topic>Retinoid X Receptors</topic><topic>Smoking</topic><topic>Transcription Factors - biosynthesis</topic><topic>Transcription Factors - genetics</topic><topic>Tumors of the respiratory system and mediastinum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MARTINET, N</creatorcontrib><creatorcontrib>ALLA, F</creatorcontrib><creatorcontrib>BORELLY, J</creatorcontrib><creatorcontrib>VERMYLEN, P</creatorcontrib><creatorcontrib>BAZARBACHI, T</creatorcontrib><creatorcontrib>VIGNAUD, J.-M</creatorcontrib><creatorcontrib>MARTINET, Y</creatorcontrib><creatorcontrib>FARRE, G</creatorcontrib><creatorcontrib>LABIB, T</creatorcontrib><creatorcontrib>DROUOT, H</creatorcontrib><creatorcontrib>VIDILI, R</creatorcontrib><creatorcontrib>PICARD, E</creatorcontrib><creatorcontrib>GAUBE, M.-P</creatorcontrib><creatorcontrib>LE FAOU, D</creatorcontrib><creatorcontrib>SIAT, J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MARTINET, N</au><au>ALLA, F</au><au>BORELLY, J</au><au>VERMYLEN, P</au><au>BAZARBACHI, T</au><au>VIGNAUD, J.-M</au><au>MARTINET, Y</au><au>FARRE, G</au><au>LABIB, T</au><au>DROUOT, H</au><au>VIDILI, R</au><au>PICARD, E</au><au>GAUBE, M.-P</au><au>LE FAOU, D</au><au>SIAT, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Retinoic acid receptor and retinoid X receptor alterations in lung cancer precursor lesions</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>2000-06-01</date><risdate>2000</risdate><volume>60</volume><issue>11</issue><spage>2869</spage><epage>2875</epage><pages>2869-2875</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract><![CDATA[Smoking prevention will decrease lung cancer incidence in time. However, early detection would improve lung cancer prognosis in subjects at risk provided that specific markers could be identified. We previously reported that retinoic acid receptor (RAR) and retinoid X receptor (RXR) expression was altered in lung tumors. RAR-beta gene status could be derived from corresponding allelotyping and immunohistochemistry data. We now report the continued study on lung cancer precursor lesions. Fluorescence PCR-based assays were used for allelotyping at the RAR/RXR loci of: (a) 66 lung precursor lesions found at the free resection margins of 41 patients undergoing surgery for lung cancer (+ 31 paired tumors); and (b) bronchial cells also found at the free resection margins from 16 current and 8 never smokers operated on for noncancerous diseases. Three microsatellites located at 3p14-21 and 9p21 were also used for interwork comparison. Immunohistochemistry was additionally performed to evaluate P53 and RAR-beta expression in precursor lesions. Chi2 tests showed significant differences (P < 0.05) when comparing the results obtained from never smokers, smokers, squamous metaplasia, dysplasia + in situ carcinoma, and tumors. Microsatellite changes occurred frequently in all samples, but without specificity for any group (P < 0.08-0.52). They were globally correlated with tobacco exposure (P < 0.04), for which the RAR-gamma marker appeared as a preferential target (P < 0.004). Few reparation error phenotypes were observed, mostly at the RXR-alpha and RXR-gamma markers for which combined changes were also linearly increasing from never smokers to dysplasia + in situ carcinoma (P < 0.05 and P < 0.03). RAR-beta marker losses also increased from the first to the last group studied (P < 0.01), with a concomitant decrease in RAR-beta protein expression and correlated p53 increased immunoreactivity (P < 0.02). Losses at 3p14, 3p21, and P16 were frequent, but no significant differences between groups could be found. Unexpectedly, high constitutive homozygosity was observed near the RAR-alpha locus in squamous cell lung cancer cases. RARs/RXRs form homodimers or heterodimers involved in ligand binding. Their added alterations could result in a state of functional vitamin A deficiency in the affected bronchial cells. Further deletion events drawn from a limited repertoire of specific regions such as 3p14-21 and 9p21 could subsequently drive the deficient cells to invasive carcinoma.]]></abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>10850430</pmid><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-5472 |
ispartof | Cancer research (Chicago, Ill.), 2000-06, Vol.60 (11), p.2869-2875 |
issn | 0008-5472 1538-7445 |
language | eng |
recordid | cdi_proquest_miscellaneous_71179655 |
source | MEDLINE; American Association for Cancer Research; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Alleles Biological and medical sciences Bronchi - metabolism Carcinoma in Situ - metabolism Epithelium - metabolism Female Genotype Humans Immunohistochemistry Lung Neoplasms - diagnosis Lung Neoplasms - genetics Lung Neoplasms - metabolism Male Medical sciences Mesothelioma - genetics Mesothelioma - metabolism Microsatellite Repeats Pneumology Precancerous Conditions - diagnosis Precancerous Conditions - genetics Precancerous Conditions - metabolism Receptors, Retinoic Acid - biosynthesis Receptors, Retinoic Acid - genetics Retinoid X Receptors Smoking Transcription Factors - biosynthesis Transcription Factors - genetics Tumors of the respiratory system and mediastinum |
title | Retinoic acid receptor and retinoid X receptor alterations in lung cancer precursor lesions |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T08%3A49%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Retinoic%20acid%20receptor%20and%20retinoid%20X%20receptor%20alterations%20in%20lung%20cancer%20precursor%20lesions&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=MARTINET,%20N&rft.date=2000-06-01&rft.volume=60&rft.issue=11&rft.spage=2869&rft.epage=2875&rft.pages=2869-2875&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E71179655%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71179655&rft_id=info:pmid/10850430&rfr_iscdi=true |